RESULTS OF A PILOT CLINICAL TRIAL OF DENDRITICCELL BASED VACCINES FOR TREATMENT OF RECURRENT HERPESVIRUS INFECTION
Chronic recurrent infections caused by herpes simplex virus (HSV) types 1 and 2 represent a serious medical and social challenge. Given an important role of immune system in surveillance of viral infections, an induced enhancement of antigen-specific immune response seems to be a promising approach...
Guardado en:
Autores principales: | O. Yu. Leplina, N. M. Starostina, D. D. Blinova, O. I. Zheltova, E. A. Oleinik, T. V. Tyrinova, A. A. Ostanin, E. R. Chernykh |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d12c8a468ba3469c88b1c2fa7c457f10 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-α
por: E. R. Chernykh, et al.
Publicado: (2019) -
Replacement of Glycoprotein B in Alcelaphine Herpesvirus 1 by Its Ovine Herpesvirus 2 Homolog : Implications in Vaccine Development for Sheep-Associated Malignant Catarrhal Fever
por: Cristina W. Cunha, et al.
Publicado: (2016) -
EFFICIENCY OF RONCOLEUKIN® IN TREATMENT OF CHRONIC RECURRENT INFECTIONS
por: O. I. Zheltova, et al.
Publicado: (2014) -
Dendritic cells in the pathogenesis of viral hepatitis C
por: Elena Removna Chernykh, et al.
Publicado: (2019) -
CYTOKINES AND HERPESVIRUSES IN CHILDREN WITH MULTIPLE SCLEROSIS
por: G. F. Zheleznikova, et al.
Publicado: (2016)